These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3552346)

  • 1. 5q- and disordered haematopoiesis.
    Bunn HF
    Clin Haematol; 1986 Nov; 15(4):1023-35. PubMed ID: 3552346
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonal evolution in a transforming 5q- syndrome.
    Kandioler D; Krieger O; Nowotny H; Lutz D
    Leukemia; 1994 Apr; 8(4):711-2. PubMed ID: 8152269
    [No Abstract]   [Full Text] [Related]  

  • 3. [5q anomaly in myelodysplasia and acute myelocytic leukemia].
    Robak T
    Acta Haematol Pol; 1990; 21(2):235-42. PubMed ID: 2151871
    [No Abstract]   [Full Text] [Related]  

  • 4. Assignment of the GM-CSF, CSF-1, and FMS genes to human chromosome 5 provides evidence for linkage of a family of genes regulating hematopoiesis and for their involvement in the deletion (5q) in myeloid disorders.
    Le Beau MM; Pettenati MJ; Lemons RS; Diaz MO; Westbrook CA; Larson RA; Sherr CJ; Rowley JD
    Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():899-909. PubMed ID: 3495397
    [No Abstract]   [Full Text] [Related]  

  • 5. [Refractory anemia with 5q--anomaly. Clinical picture and follow-up of seven patients].
    May D; Becher R
    Med Klin (Munich); 1992 Aug; 87(8):408-11. PubMed ID: 1406472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [*5q--syndrome].
    Yahata N; Ohyashiki K
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):187-90. PubMed ID: 9851117
    [No Abstract]   [Full Text] [Related]  

  • 7. The 5q- syndrome.
    Van den Berghe H
    Scand J Haematol Suppl; 1986; 45():78-81. PubMed ID: 3457446
    [No Abstract]   [Full Text] [Related]  

  • 8. Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders.
    Pettenati MJ; Le Beau MM; Lemons RS; Shima EA; Kawasaki ES; Larson RA; Sherr CJ; Diaz MO; Rowley JD
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2970-4. PubMed ID: 3495006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late appearing 5q--marker in refractory anemia.
    Heim S; Billström R; Kristoffersson U; Mandahl N; Mitelman F
    Cancer Genet Cytogenet; 1987 Jan; 24(1):159-62. PubMed ID: 3466668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5q- syndrome terminating in acute myeloid leukemia. Karyotype evolution and immunologic characterization of blast cells.
    Donti E; Tabilio A; Donti GV; Mecucci C; Carotti A; Grignani F; Martelli MF
    Cancer Genet Cytogenet; 1988 Jun; 32(2):205-9. PubMed ID: 3163260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders.
    Le Beau MM; Westbrook CA; Diaz MO; Larson RA; Rowley JD; Gasson JC; Golde DW; Sherr CJ
    Science; 1986 Feb; 231(4741):984-7. PubMed ID: 3484837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Constitutional pericentric inversions of chromosomes 5, 7 and 9 in patients with myeloid tumors].
    Ol'shanskaia IuV; Udovichenko AI; Vodinskaia LA; Savchenko VG; Domracheva EV
    Ter Arkh; 2001; 73(7):68-70. PubMed ID: 11523415
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint.
    Boultwood J; Fidler C; Lewis S; Kelly S; Sheridan H; Littlewood TJ; Buckle VJ; Wainscoat JS
    Genomics; 1994 Feb; 19(3):425-32. PubMed ID: 8188284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
    Pellagatti A; Cazzola M; Giagounidis A; Perry J; Malcovati L; Della Porta MG; Jädersten M; Killick S; Vyas P; Hellström-Lindberg E; Wainscoat JS; Boultwood J
    Br J Haematol; 2011 Oct; 155(2):272-4. PubMed ID: 21492127
    [No Abstract]   [Full Text] [Related]  

  • 15. Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q.
    Gao Q; Horwitz M; Roulston D; Hagos F; Zhao N; Freireich EJ; Golomb HM; Olopade OI
    Genes Chromosomes Cancer; 2000 Jun; 28(2):164-72. PubMed ID: 10825001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chromosome 5q deletion in a patient with persistant anemia which subsequently developed into acute non-differentiated leukemia].
    Cabrol C; Abele R
    Arch Genet (Zur); 1978; 51(2):53-5. PubMed ID: 757124
    [No Abstract]   [Full Text] [Related]  

  • 17. Dihydrofolate reductase activity in the erythroblasts of patients with 5q- syndrome.
    Nano R; Invernizzi R; Pecci A; Civallero M; Gerzeli G
    Haematologica; 2000 Jul; 85(7):765-6. PubMed ID: 10897132
    [No Abstract]   [Full Text] [Related]  

  • 18. [The 5q syndrome. 2 clinical cases].
    Pecorari P; Spangaro F; Pecile V
    Recenti Prog Med; 1987; 78(7-8):336-8. PubMed ID: 3423403
    [No Abstract]   [Full Text] [Related]  

  • 19. 5q- syndrome in a child.
    Uyttebroeck A; Brock P; De Groote B; Renard M; Dal Cin P; Van den Berghe H; Casteels-Van Daele M
    Cancer Genet Cytogenet; 1995 Apr; 80(2):121-3. PubMed ID: 7736428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution analysis of the 5q-marker chromosome in refractory anemia.
    Mitelman F; Manolova Y; Manolov G; Billström R; Heim S; Kristoffersson U; Mandahl N
    Hereditas; 1986; 105(1):49-54. PubMed ID: 3793519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.